| pubmed-article:9779806 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9779806 | lifeskim:mentions | umls-concept:C0021270 | lld:lifeskim |
| pubmed-article:9779806 | lifeskim:mentions | umls-concept:C0149575 | lld:lifeskim |
| pubmed-article:9779806 | lifeskim:mentions | umls-concept:C0752121 | lld:lifeskim |
| pubmed-article:9779806 | lifeskim:mentions | umls-concept:C0205341 | lld:lifeskim |
| pubmed-article:9779806 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:9779806 | pubmed:dateCreated | 1999-6-2 | lld:pubmed |
| pubmed-article:9779806 | pubmed:abstractText | Autosomal dominant cerebellar ataxias are a heterogeneous group of neurodegenerative disorders that generally present in adulthood. Spinocerebellar ataxia type 2 typically presents with progressive cerebellar symptoms, slow ocular saccades, and peripheral neuropathy. The onset of symptoms is usually between 20 and 40 years. We describe an infant who presented with neonatal hypotonia, developmental delay, and dysphagia. Ocular findings of retinitis pigmentosa were noted at 10 months. Her father had mild spinocerebellar ataxia first noted at age 22 years. Molecular studies of the SCA2 gene showed a CAG expansion of 43 repeats in the father and an extreme CAG repeat expansion of more than 200 in the baby. Our report expands the known phenotype and genotype of SCA2. Testing for dominant ataxias should be included in the evaluation of infants with nonspecific progressive neurologic symptoms and retinitis pigmentosa, especially in cases with a positive family history for spinocerebellar ataxia. | lld:pubmed |
| pubmed-article:9779806 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9779806 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9779806 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9779806 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9779806 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9779806 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9779806 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9779806 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9779806 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:9779806 | pubmed:issn | 0148-7299 | lld:pubmed |
| pubmed-article:9779806 | pubmed:author | pubmed-author:MichelsV VVV | lld:pubmed |
| pubmed-article:9779806 | pubmed:author | pubmed-author:PattersonM... | lld:pubmed |
| pubmed-article:9779806 | pubmed:author | pubmed-author:SnowKK | lld:pubmed |
| pubmed-article:9779806 | pubmed:author | pubmed-author:Babovic-Vuksa... | lld:pubmed |
| pubmed-article:9779806 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9779806 | pubmed:day | 12 | lld:pubmed |
| pubmed-article:9779806 | pubmed:volume | 79 | lld:pubmed |
| pubmed-article:9779806 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9779806 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9779806 | pubmed:pagination | 383-7 | lld:pubmed |
| pubmed-article:9779806 | pubmed:dateRevised | 2005-11-17 | lld:pubmed |
| pubmed-article:9779806 | pubmed:meshHeading | pubmed-meshheading:9779806-... | lld:pubmed |
| pubmed-article:9779806 | pubmed:meshHeading | pubmed-meshheading:9779806-... | lld:pubmed |
| pubmed-article:9779806 | pubmed:meshHeading | pubmed-meshheading:9779806-... | lld:pubmed |
| pubmed-article:9779806 | pubmed:meshHeading | pubmed-meshheading:9779806-... | lld:pubmed |
| pubmed-article:9779806 | pubmed:meshHeading | pubmed-meshheading:9779806-... | lld:pubmed |
| pubmed-article:9779806 | pubmed:meshHeading | pubmed-meshheading:9779806-... | lld:pubmed |
| pubmed-article:9779806 | pubmed:meshHeading | pubmed-meshheading:9779806-... | lld:pubmed |
| pubmed-article:9779806 | pubmed:meshHeading | pubmed-meshheading:9779806-... | lld:pubmed |
| pubmed-article:9779806 | pubmed:meshHeading | pubmed-meshheading:9779806-... | lld:pubmed |
| pubmed-article:9779806 | pubmed:meshHeading | pubmed-meshheading:9779806-... | lld:pubmed |
| pubmed-article:9779806 | pubmed:meshHeading | pubmed-meshheading:9779806-... | lld:pubmed |
| pubmed-article:9779806 | pubmed:meshHeading | pubmed-meshheading:9779806-... | lld:pubmed |
| pubmed-article:9779806 | pubmed:meshHeading | pubmed-meshheading:9779806-... | lld:pubmed |
| pubmed-article:9779806 | pubmed:meshHeading | pubmed-meshheading:9779806-... | lld:pubmed |
| pubmed-article:9779806 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9779806 | pubmed:articleTitle | Spinocerebellar ataxia type 2 (SCA 2) in an infant with extreme CAG repeat expansion. | lld:pubmed |
| pubmed-article:9779806 | pubmed:affiliation | Department of Medical Genetics, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA. | lld:pubmed |
| pubmed-article:9779806 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9779806 | pubmed:publicationType | Case Reports | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9779806 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9779806 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9779806 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9779806 | lld:pubmed |
